XTL BIOPHARMACEUTICALS LTD. Other Finance Income
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Other Finance Income of $34.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Income Statement › Other Income
ifrs-full:OtherFinanceIncome · last filed 2025-04-30
- XTL BIOPHARMACEUTICALS LTD. other finance income for the quarter ending 2022-06-30 was $5.00K, a 66.67% increase year-over-year.
- XTL BIOPHARMACEUTICALS LTD. other finance income for the quarter ending 2021-06-30 was $3.00K, a 76.92% decline year-over-year.
- XTL BIOPHARMACEUTICALS LTD. other finance income for the quarter ending 2020-06-30 was $13.00K.
| Period end | Other Finance Income 3 month | Other Finance Income 6 month | Other Finance Income 12 month |
|---|---|---|---|
| 2024-12-31 | $34.00K 20-F · filed 2025-04-30 | ||
| 2023-12-31 | $41.00K 20-F · filed 2025-04-30 | ||
| 2022-12-31 | $36.00K 20-F · filed 2025-04-30 | ||
| 2022-06-30 | $5.00K 6-K · filed 2022-08-24 | $8.00K 6-K · filed 2022-08-24 | |
| 2021-12-31 | $21.00K 20-F · filed 2023-03-22 | ||
| 2021-06-30 | $3.00K 6-K · filed 2022-08-24 | $5.00K 6-K · filed 2022-08-24 | |
| 2020-12-31 | $45.00K 20-F · filed 2023-03-22 | ||
| 2020-06-30 | $13.00K 6-K · filed 2021-08-24 | $25.00K 6-K · filed 2021-08-24 | |
| 2019-12-31 | $98.00K 20-F · filed 2022-03-30 | ||
| 2018-12-31 | $87.00K 20-F/A · filed 2021-05-19 | ||
| 2017-12-31 | $37.00K 20-F · filed 2020-03-12 | ||
| 2016-12-31 | $23.00K 20-F · filed 2019-03-11 | ||
| 2015-12-31 | $4.00K 20-F · filed 2018-03-15 |